NIHR Health Protection Research Unit (HPRU) - Oxford
The NIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance (AMR) is a partnership between Public Health England (PHE) and the University of Oxford in collaboration with University of Leeds, Animal and Plant Health Agency and European Bioinformatics Institute.
National Institute for Health Research (NIHR) has provided funding to establish 14 Health Protection Research Units (HPRU) to address key public health threats. The HPRUs are partnerships between Universities and Public Health England forming multi-disciplinary centres of excellence with a focus on collaborations and knowledge sharing.
HPRU in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University is led by Professor Sarah Walker and our PHE lead is Dr Susan Hopkins.
The HPRU in Healthcare Associated Infections and AMR vision is to find better ways to manage and prevent threats from antimicrobial resistance and healthcare-associated infections, by detecting them faster, working out who needs protecting most and how this can be done.
It consists of 4 broad Research Themes:
NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance
We want to create opportunities for individuals to interact, engage and contribute to our research to: Improve its quality and relevance: Ensure our research questions align with the wider public’s priorities: Disseminate findings to everyone who may find them relevant, useful or interesting: Inspire adults and children and promote careers in research and Science, Technology, Engineering, and Mathematics
Our strategy for knowledge mobilisation/policy-maker engagement is based on PHE leaders being best-placed to ensure HPRU studies directly inform PHE needs and results are disseminated beyond academia, including into PHE guidance/outputs
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
Kläser K. et al, (2022), Scientific Reports, 12
Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission
Aggarwal D. et al, (2022), Nature Communications, 13
Combining faecal immunochemical testing with blood test results for colorectal cancer risk stratification: a consecutive cohort of 16,604 patients presenting to primary care
Withrow DR. et al, (2022), BMC Medicine, 20
MR1: An unconventional twist in the tail.
Phalora P. and Klenerman P., (2022), The Journal of cell biology, 221